Literature DB >> 21971448

Imaging the Alzheimer brain.

J Wesson Ashford, Ahmad Salehi, Ansgar Furst, Peter Bayley, Giovanni B Frisoni, Clifford R Jack, Osama Sabri, Maheen M Adamson, Kerry L Coburn, John Olichney, Norbert Schuff, Daniel Spielman, Steven D Edland, Sandra Black, Allyson Rosen, David Kennedy, Michael Weiner, George Perry.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21971448      PMCID： PMC3760773          DOI： 10.3233/JAD-2011-0073

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


× No keyword cloud information.
  184 in total

Review 1.  An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.

Authors:  Allen D Roses
Journal:  Arch Neurol       Date:  2010-05

2.  Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease.

Authors:  Manja Lehmann; Jonathan D Rohrer; Matthew J Clarkson; Gerard R Ridgway; Rachael I Scahill; Marc Modat; Jason D Warren; Sebastien Ourselin; Josephine Barnes; Martin N Rossor; Nick C Fox
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

5.  An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.

Authors:  Ningnannan Zhang; Xiaowei Song; Yunting Zhang; Wei Chen; Ryan C N D'Arcy; Sultan Darvesh; John D Fisk; Kenneth Rockwood
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Resting state cortical rhythms in mild cognitive impairment and Alzheimer's disease: electroencephalographic evidence.

Authors:  Claudio Babiloni; Fabrizio Vecchio; Roberta Lizio; Raffaele Ferri; Guido Rodriguez; Nicola Marzano; Giovanni B Frisoni; Paolo M Rossini
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 7.  Neuropathology of Alzheimer's disease and related disorders.

Authors:  D P Perl
Journal:  Neurol Clin       Date:  2000-11       Impact factor: 3.806

8.  Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers.

Authors:  Paul R Borghesani; L Clark Johnson; Amy L Shelton; Elaine R Peskind; Elizabeth H Aylward; Gerard D Schellenberg; Monique M Cherrier
Journal:  Neurobiol Aging       Date:  2007-03-09       Impact factor: 4.673

9.  A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.

Authors:  Sofia Tzimopoulou; Vincent J Cunningham; Thomas E Nichols; Graham Searle; Nick P Bird; Prafull Mistry; Ian J Dixon; William A Hallett; Brandon Whitcher; Andrew P Brown; Marina Zvartau-Hind; Narinder Lotay; Robert Y K Lai; Mary Castiglia; Barbara Jeter; Julian C Matthews; Kewei Chen; Dan Bandy; Eric M Reiman; Michael Gold; Eugenii A Rabiner; Paul M Matthews
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals.

Authors:  Maija Pihlajamäki; Reisa A Sperling
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342
View more
  9 in total

1.  Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.

Authors:  Jane M Johnston; William T Hu; David W Fardo; Steven J Greco; George Perry; Thomas J Montine; John Q Trojanowski; Leslie M Shaw; J Wesson Ashford; Nikolaos Tezapsidis
Journal:  Curr Alzheimer Res       Date:  2014-02       Impact factor: 3.498

Review 2.  A Brief Introduction to Magnetoencephalography (MEG) and Its Clinical Applications.

Authors:  Alfred Lenin Fred; Subbiahpillai Neelakantapillai Kumar; Ajay Kumar Haridhas; Sayantan Ghosh; Harishita Purushothaman Bhuvana; Wei Khang Jeremy Sim; Vijayaragavan Vimalan; Fredin Arun Sedly Givo; Veikko Jousmäki; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Brain Sci       Date:  2022-06-15

3.  Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease.

Authors:  Eric McDade; Albert Kim; Jeffrey James; Lei K Sheu; Dora Chieh-Hsin Kuan; Davneet Minhas; Peter J Gianaros; Snezana Ikonomovic; Oscar Lopez; Beth Snitz; Julie Price; Jim Becker; Chet Mathis; William Klunk
Journal:  Neurology       Date:  2014-07-16       Impact factor: 9.910

Review 4.  A review of β-amyloid neuroimaging in Alzheimer's disease.

Authors:  Paul A Adlard; Bob A Tran; David I Finkelstein; Patricia M Desmond; Leigh A Johnston; Ashley I Bush; Gary F Egan
Journal:  Front Neurosci       Date:  2014-10-31       Impact factor: 4.677

Review 5.  The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and Tau.

Authors:  J Wesson Ashford
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 6.  Role of Chemokines in the Development and Progression of Alzheimer's Disease.

Authors:  Jakub Wojcieszak; Katarzyna Kuczyńska; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2022-07-12       Impact factor: 2.866

Review 7.  Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?

Authors:  Emilio Merlo Pich; Andreas Jeromin; Giovanni B Frisoni; Derek Hill; Andrew Lockhart; Mark E Schmidt; Martin R Turner; Stefania Mondello; William Z Potter
Journal:  Alzheimers Res Ther       Date:  2014-07-30       Impact factor: 6.982

8.  Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease.

Authors:  Ying Liu; Jin-Tai Yu; Hui-Fu Wang; Xiao-Ke Hao; Yu-Fen Yang; Teng Jiang; Xi-Chen Zhu; Lei Cao; Dao-Qiang Zhang; Lan Tan
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

Review 9.  Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease.

Authors:  Marta Milà-Alomà; Marc Suárez-Calvet; José Luís Molinuevo
Journal:  Ther Adv Neurol Disord       Date:  2019-12-18       Impact factor: 6.570
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.